M. Bassendine

HCV and the hepatic lipid pathway as a potential treatment target.

M. Bassendine, R. Neely, D. Felmlee, 2011, Journal of hepatology.

Lipids and HCV

M. Bassendine, R. Neely, D. Felmlee, 2012, Seminars in Immunopathology.

Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas.

C. Challen, J. Collier, K. Guo, 1992, Journal of hepatology.

T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC)

S. Yeaman, M. Bassendine, D. Jones, 1999, Clinical and experimental immunology.

Metabolic bone disease in primary biliary cirrhosis at presentation.

M. Bassendine, O. James, A. Malcolm, 1988, Gastroenterology.

Expression of transforming growth factor alpha in human hepatocellular carcinoma.

W. Gullick, A. Burt, M. Bassendine, 2008, Liver.

Fatigue in primary biliary cirrhosis

A. Oatridge, S. Taylor-Robinson, M. Prince, 2005, Gut.

Expression of glutathione S-transferases in normal and malignant pancreas: an immunohistochemical study.

M. Bennett, M. Bassendine, J. Collier, 1994, Gut.

Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency

H. Thomas, S. Taylor-Robinson, M. Bassendine, 2014, Metabolic Brain Disease.

c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.

M. Bennett, M. Bassendine, J. Collier, 1992, Journal of hepatology.

Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis.

David C. Jones, S. Pearce, A. Floreani, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis

D. Jones, M. Bassendine, G. Spickett, 1995, Clinical and experimental immunology.